Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 4839Sesión 2025-2026

Qué cambió entre versiones

15 párrafos cambiaron+109 palabras agregadas−202 eliminadas

El texto resaltado se agregó en la versión más reciente. El texto tachado se eliminó.

substitute for

HOUSEHouse BILL NO. 4839

A bill to amend 1939 PA 280, entitled

"The social welfare act,"

(MCL 400.1 to 400.119b) by adding section 109z.

the peoplepeoplE of the state of michigan enact:

Sec. 109z. (1) TheExcept as otherwise provided in subsection (2), the department shall not provide coverage under the medical assistance program for a brand name drug or biological drug product if ana lower cost generically equivalent genericdrug nameor interchangeable biological drug product exists unless any of the following apply to the prescription for the brand name drug:.

(a) The prescriber, in the case of a prescription in writing signed by the prescriber, writes in the prescriber's own handwriting "dispense as written" or "d.a.w." on the prescription.

(b) The prescriber, having preprinted on the prescriber's prescription blanks the statement "another brand of a generically equivalent product, identical in dosage, form, and content of active ingredients, may be dispensed unless initialed d.a.w.", writes in the prescriber's own handwriting the initials "d.a.w." in a space, box, or square adjacent to the statement.

(c) The prescriber, in the case of a prescription other than one in writing signed by the prescriber, expressly indicates that the prescription is to be dispensed as communicated.

(2) The department shall provide coverage under the medical assistance program for a brand name drug product or biological drug product if any of the circumstances described in section 17755(3)(a), (b), or (c) of the public health code, 1978 PA 368, MCL 333.17755, apply.

(23) As used in this section:

(a) "Brand name" means the registered trademark name given to a drug product by its manufacturer.

(a) "Biological drug product" means that term as defined in section 17702 of the public health code, 1978 PA 368, MCL 333.17702.

(b) "DispenseBrand name" means that term as defined underin section 1770317702 of the public health code, 1978 PA 368, MCL 333.1770317702.

(c) "Drug" means that term as defined under section 17703 of the public health code, 1978 PA 368, MCL 333.17703.

(d) "Generic name" means the established or official name of a drug or drug product.

(ed) "PrescriberInterchangeable biological drug product" means that term as defined underin section 1770817704 of the public health code, 1978 PA 368, MCL 333.1770817704.

(f) "Prescription" means that term as defined under section 17708 of the public health code, 1978 PA 368, MCL 333.17708.

Volver al texto completo